Bisphosphonates for the treatment of fibrous dysplasia of bone
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Medical Therapy in Adults With Fibrous Dysplasia of BoneJournal of Bone and Mineral Research, 2006
- Gsα Mutations in Fibrous Dysplasia and McCune-Albright SyndromeJournal of Bone and Mineral Research, 2006
- Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancerAnnals of Oncology, 2006
- Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's DiseaseNew England Journal of Medicine, 2005
- Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremityArthritis & Rheumatism, 2004
- Renal Phosphate Wasting in Fibrous Dysplasia of Bone Is Part of a Generalized Renal Tubular Dysfunction Similar to That Seen in Tumor-Induced OsteomalaciaJournal of Bone and Mineral Research, 2001
- Alendronate Induces Antinociception in Mice, Not Related With Its Effects in BoneThe Japanese Journal of Pharmacology, 1999
- Long-Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of BoneJournal of Bone and Mineral Research, 1997
- Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone DensityJournal of Bone and Mineral Research, 1997
- Long-term effects of intravenous pamidronate in fibrous dysplasia of boneThe Lancet, 1994